4//SEC Filing
Clark David J 4
Accession 0000950170-24-016464
CIK 0001563880other
Filed
Feb 15, 7:00 PM ET
Accepted
Feb 16, 4:43 PM ET
Size
5.4 KB
Accession
0000950170-24-016464
Insider Transaction Report
Form 4
Clark David J
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2024-02-15+175,000→ 175,000 totalExercise: $2.38Exp: 2034-02-14→ Common Stock (175,000 underlying)
Footnotes (1)
- [F1]This option was granted on February 15, 2024. The 175,000 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 15, 2025 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 15, 2028.
Documents
Issuer
Trevi Therapeutics, Inc.
CIK 0001563880
Entity typeother
Related Parties
1- filerCIK 0001662693
Filing Metadata
- Form type
- 4
- Filed
- Feb 15, 7:00 PM ET
- Accepted
- Feb 16, 4:43 PM ET
- Size
- 5.4 KB